Recall Enforment Report D-1049-2019

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Legacy Pharmaceutical Packaging LLC, originally initiated on 03-01-2019 for the product Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045. NDC 68645-578-54 The product was recalled due to cgmp deviations: presence of an impurity, n-methylnitrosobutyric acid (nmba) detected. The product was distributed in Wal-mart Distribution Centers In Ar, Ca, Ga, In And Md and the recall is currently ongoing.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-1049-201903-01-201903-27-2019Class II2,851,284 bottlesLosartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045. NDC 68645-578-54CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detectedOngoing
D-1048-201903-01-201903-27-2019Class II456,732 bottlesLosartan Potassium Tablets, USP, 25 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-577-54CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detectedOngoing
D-1050-201903-01-201903-27-2019Class II2,497,856 bottlesLosartan Potassium Tablets, USP, 100 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045. NDC 68645-579-54CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detectedOngoing